SCHEMBL5049477

SCHEMBL5049477

C=C(COc1ccc2nc(-c3ccc(C=C(C(=O)OCC)C(=O)OCC)cc3)oc2c1)O[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
POLB P06746 1/20 0.42
THRB P10828 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
GPR119 Q8TDV5 4/20 0.38
TDP1 Q9NUW8 1/20 0.38
HSP90AA1 P07900 1/20 0.37
HTT P42858 1/20 0.37
TLR7 Q9NYK1 3/20 0.37
LMNA P02545 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
S1PR4 O95977 1/20 0.36
S1PR1 P21453 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041476 0.88 MAPT (0.43) MAPTSMN1; SMN2POLBTHRBNR1H4
SCHEMBL14095569 0.85 MAPT (0.41) MAPTSMN1; SMN2POLBTHRBNR1H4
SCHEMBL5049478 0.85 MAPT (0.37) MAPTSMN1; SMN2POLBTHRBGPR119
SCHEMBL5044883 0.80 TLR7 (0.48) MAPTSMN1; SMN2POLBNR1H4TLR7
SCHEMBL5045843 0.77 ESR1 (0.55) MAPTSMN1; SMN2NR1H4GPR119LMNA
SCHEMBL5042502 0.76 TLR7 (0.39) MAPTSMN1; SMN2POLBNR1H4GPR119
SCHEMBL5045089 0.74 MEN1 (0.57) MAPTSMN1; SMN2NR1H4TDP1HSP90AA1
SCHEMBL5041479 0.74 MAPT (0.38) MAPTSMN1; SMN2POLBTHRBGPR119
SCHEMBL14135761 0.71 TLR7 (0.44) MAPTSMN1; SMN2POLBTHRBGPR119
SCHEMBL14095573 0.69 MAPT (0.49) MAPTSMN1; SMN2NR1H4TDP1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414138-B2 Benzoxazole and benzodiazole UV-A sunscreens DSM IP ASSETS B.V. (NL) 2008-08-19 US disclosed
US-20050260144-A1 Benzoxazole and benzodiazole uv-a sunscreens DSM IP ASSETS B.V. (NL) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260144-A1 Benzoxazole and benzodiazole uv-a sunscreens SUN2, CYP27B1, ERCC4 MAPT 543/4885SMN1; SMN2 3995/4885POLB 1200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.